OptiNose Inc (OPTN)
1.01
+0.13
(+15.09%)
USD |
NASDAQ |
May 03, 16:00
1.003
-0.01
(-0.72%)
After-Hours: 20:00
OptiNose Free Cash Flow (Quarterly): 6.836M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.836M |
| September 30, 2023 | -4.601M |
| June 30, 2023 | -12.62M |
| March 31, 2023 | -10.48M |
| December 31, 2022 | -17.68M |
| September 30, 2022 | -17.51M |
| June 30, 2022 | -13.14M |
| March 31, 2022 | -19.38M |
| December 31, 2021 | -16.74M |
| September 30, 2021 | -9.729M |
| June 30, 2021 | -22.52M |
| March 31, 2021 | -28.12M |
| December 31, 2020 | -19.24M |
| September 30, 2020 | -15.68M |
| Date | Value |
|---|---|
| June 30, 2020 | -23.79M |
| March 31, 2020 | -28.04M |
| December 31, 2019 | -18.18M |
| September 30, 2019 | -15.19M |
| June 30, 2019 | -28.14M |
| March 31, 2019 | -29.86M |
| December 31, 2018 | -20.43M |
| September 30, 2018 | -24.70M |
| June 30, 2018 | -24.99M |
| March 31, 2018 | -23.38M |
| December 31, 2017 | -15.00M |
| September 30, 2017 | -8.743M |
| June 30, 2017 | -6.725M |
| March 31, 2017 | -7.62M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-28.14M
Minimum
Jun 2019
6.836M
Maximum
Dec 2023
-16.52M
Average
-17.51M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -16.23M |
| Madrigal Pharmaceuticals Inc | -80.97M |
| Viking Therapeutics Inc | -6.134M |
| Spero Therapeutics Inc | -17.49M |
| Karuna Therapeutics Inc (DELISTED) | -111.86M |